Misleading hepatitis C serology following administration of intravenous immunoglobulin.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8135190.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intravenous immunoglobulin (IVIG) is a blood derivative that is being evaluated for the prevention and treatment of numerous disorders. Recent studies have suggested beneficial effects from the prophylactic administration of IVIG to very-low-birth-weight neonates. A disadvantage of such therapy is misleading infectious disease serologic assays following administration of IVIG. The authors report a recent case in their neonatal intensive care unit of a 24-week gestational age girl with a misleading positive hepatitis C serology reaction following IVIG administration.
Medical subject headings
- Hepatitis C
- Immunoglobulins
- Infant, Low Birth Weight